These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 36263706)
1. Synthesis, structural studies, interaction with DNA/HSA and antitumor evaluation of new Cu(II) complexes containing 2-(1 Cai DH; Chen BH; Liu QY; Le XY; He L Dalton Trans; 2022 Nov; 51(43):16574-16586. PubMed ID: 36263706 [TBL] [Abstract][Full Text] [Related]
2. Synthesis, DNA binding, antibacterial and anticancer properties of two novel water-soluble copper(II) complexes containing gluconate. Cai DH; Zhang CL; Liu QY; He L; Liu YJ; Xiong YH; Le XY Eur J Med Chem; 2021 Mar; 213():113182. PubMed ID: 33486198 [TBL] [Abstract][Full Text] [Related]
3. Synthesis, characterization and biological activity of novel copper complexes containing a β-carboline derivative and amino acids. Chen BH; Pan ZY; Feng WW; Liu QY; Liu Y; He L Dalton Trans; 2023 Jun; 52(23):8040-8050. PubMed ID: 37227152 [TBL] [Abstract][Full Text] [Related]
4. Protein binding studies with human serum albumin, molecular docking and in vitro cytotoxicity studies using HeLa cervical carcinoma cells of Cu(ii)/Zn(ii) complexes containing a carbohydrazone ligand. Parsekar SU; Velankanni P; Sridhar S; Haldar P; Mate NA; Banerjee A; Sudhadevi Antharjanam PK; Koley AP; Kumar M Dalton Trans; 2020 Mar; 49(9):2947-2965. PubMed ID: 32073070 [TBL] [Abstract][Full Text] [Related]
5. Sparfloxacin - Cu(II) - aromatic heterocyclic complexes: synthesis, characterization and Liu QY; Qi YY; Cai DH; Liu YJ; He L; Le XY Dalton Trans; 2022 Jun; 51(25):9878-9887. PubMed ID: 35713093 [TBL] [Abstract][Full Text] [Related]
7. Synthesis, characterization, DNA/HSA interactions and in vitro cytotoxic activities of two novel water-soluble copper(II) complexes with 1,3,5-triazine derivative ligand and amino acids. Zhang CL; Liu YX; Zhang XM; Chen S; Shen F; Xiong YH; Liu W; Mao ZW; Le XY Mater Sci Eng C Mater Biol Appl; 2018 Oct; 91():414-425. PubMed ID: 30033272 [TBL] [Abstract][Full Text] [Related]
8. Thiosemicarbazone Cu(II) and Zn(II) complexes as potential anticancer agents: syntheses, crystal structure, DNA cleavage, cytotoxicity and apoptosis induction activity. Shao J; Ma ZY; Li A; Liu YH; Xie CZ; Qiang ZY; Xu JY J Inorg Biochem; 2014 Jul; 136():13-23. PubMed ID: 24690556 [TBL] [Abstract][Full Text] [Related]
9. A novel water-soluble Cu(II) gluconate complex inhibits cancer cell growth by triggering apoptosis and ferroptosis related mechanisms. Cai DH; Liang BF; Chen BH; Liu QY; Pan ZY; Le XY; He L J Inorg Biochem; 2023 Sep; 246():112299. PubMed ID: 37354603 [TBL] [Abstract][Full Text] [Related]
10. Redox-cycling and intercalating properties of novel mixed copper(II) complexes with non-steroidal anti-inflammatory drugs tolfenamic, mefenamic and flufenamic acids and phenanthroline functionality: Structure, SOD-mimetic activity, interaction with albumin, DNA damage study and anticancer activity. Simunkova M; Lauro P; Jomova K; Hudecova L; Danko M; Alwasel S; Alhazza IM; Rajcaniova S; Kozovska Z; Kucerova L; Moncol J; Svorc L; Valko M J Inorg Biochem; 2019 May; 194():97-113. PubMed ID: 30849593 [TBL] [Abstract][Full Text] [Related]
11. Cu(ii)-TACN complexes selectively induce antitumor activity in HepG-2 cells via DNA damage and mitochondrial-ROS-mediated apoptosis. Liu M; Song XQ; Wu YD; Qian J; Xu JY Dalton Trans; 2020 Jan; 49(1):114-123. PubMed ID: 31793575 [TBL] [Abstract][Full Text] [Related]
12. Structure and biological properties of mixed-ligand Cu(II) Schiff base complexes as potential anticancer agents. Gou Y; Li J; Fan B; Xu B; Zhou M; Yang F Eur J Med Chem; 2017 Jul; 134():207-217. PubMed ID: 28415010 [TBL] [Abstract][Full Text] [Related]
13. Two New Mononuclear Copper(II)-Dipeptide Complexes of 2-(2'-Pyridyl)Benzoxazole: DNA Interaction, Antioxidation and in Vitro Cytotoxicity Studies. Gan Q; Qi Y; Xiong Y; Fu Y; Le X J Fluoresc; 2017 Mar; 27(2):701-714. PubMed ID: 27981404 [TBL] [Abstract][Full Text] [Related]
14. Four Cu(ii) complexes based on antitumor chelators: synthesis, structure, DNA binding/damage, HSA interaction and enhanced cytotoxicity. Liu YH; Li A; Shao J; Xie CZ; Song XQ; Bao WG; Xu JY Dalton Trans; 2016 May; 45(19):8036-49. PubMed ID: 27071545 [TBL] [Abstract][Full Text] [Related]
15. Piperidylthiosemicarbazones Cu(II) complexes with a high anticancer activity by catalyzing hydrogen peroxide to degrade DNA and promote apoptosis. Qi J; Yao Q; Tian L; Wang Y Eur J Med Chem; 2018 Oct; 158():853-862. PubMed ID: 30248656 [TBL] [Abstract][Full Text] [Related]
16. Mixed-ligand copper(ii) Schiff base complexes: the role of the co-ligand in DNA binding, DNA cleavage, protein binding and cytotoxicity. Lian WJ; Wang XT; Xie CZ; Tian H; Song XQ; Pan HT; Qiao X; Xu JY Dalton Trans; 2016 May; 45(22):9073-87. PubMed ID: 27163172 [TBL] [Abstract][Full Text] [Related]
17. DNA binding, cleavage and cytotoxicity studies of three mononuclear Cu(II) chloro-complexes containing N-S donor Schiff base ligands. Parsekar SU; Fernandes J; Banerjee A; Chouhan OP; Biswas S; Singh M; Mishra DP; Kumar M J Biol Inorg Chem; 2018 Dec; 23(8):1331-1349. PubMed ID: 30302601 [TBL] [Abstract][Full Text] [Related]
18. Influence of anchoring moieties on new benzimidazole-based Schiff base copper(II) complexes towards estrogen dependent breast cancer cells. Paul A; Singh P; Kuznetsov ML; Karmakar A; Guedes da Silva MFC; Koch B; Pombeiro AJL Dalton Trans; 2021 Mar; 50(10):3701-3716. PubMed ID: 33634805 [TBL] [Abstract][Full Text] [Related]
20. Two water-soluble copper(II) complexes: synthesis, characterization, DNA cleavage, protein binding activities and in vitro anticancer activity studies. Lu J; Sun Q; Li JL; Jiang L; Gu W; Liu X; Tian JL; Yan SP J Inorg Biochem; 2014 Aug; 137():46-56. PubMed ID: 24803026 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]